Cost-effectiveness of a multicomponent-adherence intervention in fracture liaison services

BackgroundThis study aims to assess the lifetime cost-effectiveness of a multi-component adherence intervention (MCAI), including a patient decision aid and motivational interviewing, compared to usual care in patients with a recent fracture attending fracture liaison services (FLS) and eligible for anti-osteoporosis medication (AOM).Research design and methodsData on AOM initiation and one-year persistence were collected from a quasi-experimental study conducted between 2019 and 2023 in two Dutch FLS centers. An individual level, state-transition Markov model was used to simulate lifetime costs and quality-adjusted life years (QALYs) with a societal perspective of MCAI vs usual care. One-way and probabilistic sensitivity analyses were conducted including variation in additional FLS and MCAI costs (no MCAI cost in baseline).ResultsMCAI was associated with gain in QALYs (0.0012) and reduction in costs (-16) and is therefore dominant. At the Dutch willingness-to-pay threshold of 50,000/QALY, MCAI remained cost-effective when increasing costs of the FLS visit or the yearly maintenance cost for MCAI up to +60. Probabilistic sensitivity analysis demonstrated MCAI to be dominant in 54% of the simulations and cost-effective in 87% with a threshold of 50,000/QALY.ConclusionsA MCAI implemented in FLS centers may lead to cost-effective allocation of resources in FLS care, depending on extra costs.